All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
Introducing
Now you can personalise
your GvHD Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Bookmark this article
The severe consequences of acute graft-versus-host disease (aGvHD) following allogeneic hematopoietic stem cell transplantation are driving scientists to investigate new therapeutic options. The pathogenesis of aGvHD involves the activation of host antigen-presenting cells, donor T cells, and subsequent inflammation. Macrophages have two major polarization pathways, M1 and M2, and the imbalance of these has been found in many immune disorders. Macrophages have also been shown to be associated with aGvHD pathogenesis, but there is a lack of studies that demonstrate the involvement of macrophage polarization.
Arsenic trioxide (ATO) is an environmental toxic agent that is associated with cancer development. Recently, it has been identified as a potent treatment option for patients with promyelocytic leukemia. Xiao Liu and colleagues have conducted a preclinical study to investigate the role of macrophage polarization in aGvHD and ATO as an option for aGvHD management. Here, we summarize the results Liu presented during the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress.1,2
Macrophage polarization was analyzed in the macrophages from the colon tissue of mice with or without GvHD.
Peripheral blood from patients with aGvHD was used to isolate macrophages which were cultured in the presence or absence of ATO, and then analyzed for expression of CD86, CD80, CD163, and CD206.
To investigate the effect of ATO in GvHD mouse models:
The evaluation was carried out in three mice groups: (i) donor mice (bone marrow [BM] group), (ii) mice with GvHD but not treated with ATO (GvHD group), and (iii) mice with GvHD treated with ATO (ATO group).
The in vitro data suggest that aGvHD is accompanied by M1-type macrophage polarization, which may indicate another mechanism for aGvHD development. In animal GvHD models and peripheral blood from patients with aGvHD, ATO is able to revert the M1/M2 imbalance and may therefore have potential in the treatment of aGvHD that needs further evaluation in future studies.
Subscribe to get the best content related to GvHD delivered to your inbox